Adaptive Monitoring: The First Implementation Steps in Real-Life

By |2018-03-07T12:56:48+02:00February 13, 2018|Blog, Case Studies|1 Comment

It is widely broadcasted that pharma companies will have to accelerate adoption of adaptive clinical trial designs to reduce study timelines and costs while increasing success rates. Risk-based Monitoring “Real RBM” integrates the Adaptive Monitoring (AM) process, which addresses all aspects of Quality Risk Management.